Geriatric Assessment Improves Communication Between Oncologists and Older Patients

For immediate release
June 1, 2018

MEDIA CONTACT:
Alise Fisher
571-483-1354
alise.fisher@asco.org

PATIENT AND CAREGIVER INQUIRIES:
Contact Cancer.Net

 

ASCO Perspective
“As a society, we often think about the value of cancer treatments in terms of survival, but for older patients, we need to look beyond that. Geriatric assessments are clearly an effective tool to help us treat the whole patient. It’s a conversation starter that informs and empowers both patients and oncologists as we make decisions about their cancer care and overall health care together,” said ASCO Expert Joshua A. Jones, MD, MA.

CHICAGO – A federally funded randomized study demonstrated that the use of geriatric assessment in routine care of older adults with advanced cancer significantly improved doctor-patient communication about age-related concerns as well as patient satisfaction with the communication.

Geriatric assessment is an evaluation of health-related concerns common among older adults. In this study, the geriatric assessment included a standardized, written questionnaire and objective tests for physical performance and cognition. Researchers evaluated all patients with geriatric assessment, but only oncologists at practices randomly assigned to the intervention arm received results of the geriatric assessment. Researchers found that doctors who received geriatric assessment results before meeting with their patient were more likely to discuss age-related concerns and recommend interventions to address them.

This is the first randomized study to show that geriatric assessment improves doctor-patient communication, according to the authors. The study will be featured in a press briefing today and presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

“As oncologists, we need to step away from focusing solely on the cancer, especially in our older patients. While living longer is important, there are many non-cancer related health issues that are as, if not more, important,” said lead study author Supriya Gupta Mohile, MD, MS, the Wehrheim professor of medicine at the University of Rochester in New York. “Both patients and their caregivers clearly want the oncologist to discuss age-related concerns. Our study shows that geriatric assessment can help oncologists meet these needs for their older patients.”

Approximately 70% of people with cancer are age 65 and older, and the number of people with cancer over the age of 65 is projected to increase significantly over the next 20 years.1

About Geriatric Assessment
Geriatric assessment is the evaluation of age-related concerns pertaining to physical and mental health, nutrition, and social support, which are often not identified during a routine oncology visit and physical exam. The assessment can identify older adults who are at risk of having a shorter life expectancy due to non-cancer related health problems and people at increased risk of side effects from cancer treatment.

In a recently published clinical practice guideline, ASCO recommended that geriatric assessment be used to identify vulnerabilities that are not routinely captured in oncology assessments in all patients 65 years and older who are receiving chemotherapy.

Research suggests geriatric assessment is most widely used in major cancer centers with geriatric oncology programs, but seldomly used in other practice settings.2,3

About the Study
In this study, the researchers randomly assigned 31 community oncology practices that are affiliated with the University of Rochester’s NCI Community Oncology Research Program to geriatric assessment group or usual care group. Through these practices, information from 542 patients was included in this study. All were age 70 years or older, with incurable, advanced solid tumors or lymphoma, and had an impairment in at least one measure on the geriatric assessment performed at study enrollment.

The measures included function (activities of daily living), physical performance (e.g., balance, falls, physical health), comorbidities (chronic illnesses), nutrition, social support, depression, and cognition (e.g., memory problems).

As part of the geriatric assessment, physical performance and cognition measures were assessed through objective tests given by trained coordinators. Other measures were self-reported through validated questionnaires. On average, the questionnaires took patients 30-45 minutes to complete and the objective tests another 10 minutes in the clinic.

Although patients in both study arms received geriatric assessment, only oncologists in the geriatric assessment arm received a web-based summary of results from the assessment with recommendations for interventions for each patient (e.g., physical therapy for a history of falls) prior to their next clinic visit. In the usual care group, physicians were informed if geriatric assessment revealed a patient had significantly impaired cognition or depression, but they received no overall summary of results of the assessments or recommendations for care.

Clinic visits occurred within four weeks of the geriatric assessment. Researchers assessed the content and quality of doctor-patient communication through transcribed recordings of the conversation during one clinic visit for each patient in both study arms. Quality communication was defined as conversations where the physician gathered more information about age-related concerns and patients’ concerns were addressed thoroughly. Patient satisfaction with doctor-patient communication was assessed through a telephone questionnaire following the clinic visit.

Key Findings
In the geriatric assessment arm, there was a mean of 3.5 more discussions about age-related concerns during the clinic visits, compared to the usual care arm. On average, there were two more high-quality doctor-patient conversations in the geriatric assessment arm than in the usual care arm, and two more discussions led to interventions in the geriatric assessment arm than in the usual care arm.

Interventions included physical therapy evaluation for patients with a history of falls; reducing or eliminating high-risk medications for a patient taking more than five prescription medications; and assessing decisional capacity in a patient with significant cognitive impairment.

Patients in the geriatric assessment arm had significantly more discussions about almost all age-related concerns measured by geriatric assessment. Patient satisfaction with communication with their doctor was 1.12 points higher in the geriatric assessment arm (difference statistically significant), suggesting that patients valued discussions about age-related concerns.

Next Steps
The researchers are evaluating if the interventions resulting from geriatric assessments have a positive effect on patient function and quality of life, and caregiver satisfaction and quality of life.  A separate ongoing study is evaluating if geriatric assessment can reduce chemotherapy side effects by improving decision making for older patients with advanced cancer. There are several other randomized clinical trials underway evaluating the effects of geriatric assessment on other outcomes. 

This study received funding from the Patient Centered Outcomes Research Institute and the National Cancer Institute. All statements from this study, including its findings and conclusions, are solely those of the authors, and do not necessarily represent the official views of the funding agencies, PCORI, its Board of Governors, or its Methodology Committee.

Study at a Glance

Disease

Advanced solid tumors and lymphoma

Trial Type

Cluster randomized clinical trial

Patients on Trial

542

Intervention Tested

Geriatric assessment

Primary Finding

Geriatric assessment helps improve communication about age-related concerns between older patients and their oncologists

Secondary Finding(s)

More age-related problems addressed when geriatric assessment used

 

View the full abstract.

For your readers:

View the disclosures for the 2018 ASCO Annual Meeting News Planning Team.

ATTRIBUTION TO THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING IS REQUESTED IN ALL COVERAGE.

###

1Smith BD, Smith GL, Hurria A, et al: Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27:2758-65, 2009
2McNeil C.   Geriatric oncology clinics on the rise.  JNCI 2013 May 1. 1;105(9):585-6.
3Mohile SG.  Community Oncologists’ Decision-Making for Treatment of Older Patients with Cancer.  JNCCN.  2018 March; 16(3):301-309

About ASCO: 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents nearly 45,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.